- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03221452
Adaptation of a Cognitive Training Intervention for Diabetes Self-Management
14 juli 2017 bijgewerkt door: University of Texas at Austin
The aims of this project are: (1) to refine an existing cognitive rehabilitation intervention and tailor it for persons with T2DM by using current literature and interview data from 10 participants with T2DM and (2) to conduct a feasibility study of the adapted intervention with 20 participants with T2DM.
The intervention consists of 8 weekly group educational sessions to teach compensatory cognitive strategies.
Participants will also use a web-based, game-like program to build on the didactic information and practice activities to improve cognitive health.
Studie Overzicht
Toestand
Onbekend
Interventie / Behandeling
Gedetailleerde beschrijving
Type 2 diabetes mellitus (T2DM) increases the risk for cognitive impairment and doubles the rate of cognitive decline after diabetes is diagnosed.
In turn, the presence of cognitive dysfunction can make diabetes self-management more difficult.
Few interventions have attempted to focus on cognitive function in the context of diabetes and none, to date have tested an intervention to improve cognition in order to improve diabetes self-management.
Therefore the aims of this project are: (1) to refine an existing cognitive rehabilitation intervention and tailor it for persons with T2DM by using current literature and interview data from 10 participants with T2DM and (2) to conduct a feasibility study of the adapted intervention with 20 participants with T2DM.
The intervention consists of 8 weekly group educational sessions to teach compensatory cognitive strategies.
Additionally, participants will use a web-based, game-like program to build on the didactic information and practice activities to improve cognitive health.
The project will provide baseline data for further research on diabetes self-management in the context of cognitive dysfunction.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
29
Fase
- Niet toepasbaar
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
40 jaar tot 70 jaar (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Age 40 to 70
- Have been diagnosed with type 2 diabetes for at least 2 years
- Score of at least 10 on the Perceived Deficits Questionnaire
- Read and write in English
- Have access to transportation and telephone and Internet services
Exclusion Criteria:
- limitations that preclude study activities
- have been diagnosed with dementia or disorders that can affect cognition such as depression
- type 1 diabetes
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: Intervention
The intervention includes 4 every other week, 2-hour educational sessions to teach compensatory strategies along with skill development and training.
Educational sessions will include content on common cognitive problems experienced by people with T2DM and discussion of compensatory strategies to improve cognitive skills as well as content on behaviors and lifestyle strategies to maintain cognitive functioning.
Each participant will use the online training program (BrainHQ/Posit Science) for a minimum of 45 minutes 3 times a week and to record practice times and dates.
Tasks in the computer training are arranged so that as the user moves forward, the tasks become more challenging.
Each task is in a game-like format.
|
Classes will include: (1) information on diabetes self-management including glucose self-monitoring and medication management; (2) assessment of cognitive problems; (3) resources and barriers to self-management; and (4) lifestyle changes to maximize cognitive health.
Participants will also practice those skills with online computer games.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Diabetes Self-Care Activities
Tijdsspanne: Baseline and immediately post-intervention
|
Summary of Diabetes Self-Care Activities Questionnaire; 18 items; Participants answer questions regarding how many days in the last week have they performed a certain aspect of diabetes self-management behaviors such as diet, smoking, and physical activity.
|
Baseline and immediately post-intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
General Self-Efficacy Scale
Tijdsspanne: Baseline and immediately post-intervention
|
10 items; confidence in ability to influence outcomes.
Responses are made on a 4-point scale (1 = not true at all, 2= hardly true, 3 = moderately true, 4= exactly true) to items such as "I can always manage to solve difficult problems If I try hard enough."
|
Baseline and immediately post-intervention
|
|
Multifactorial Memory Questionnaire
Tijdsspanne: Baseline and immediately post-intervention
|
57 items; assesses contentment with one's memory, subjective memory capability, and use of memory aids.
Participants rate their level of agreement with each item on a 5-point scale (strongly agree = 1, agree = 2, undecided = 3, disagree = 4, strongly disagree = 5) for the Contentment subscale; The Ability subscale asks participants to indicate the frequency with which each memory failure has occurred in the past 2 weeks on a 5-point scale (all the time = 1, often =2, sometimes = 3, rarely =4, never =5); The third subscale, Strategy, asks participants to rate the frequency of use of certain memory strategies on a 5-point scale (never =1, rarely =2, sometimes =3, often =4, all the time =5).
|
Baseline and immediately post-intervention
|
|
Change in executive function
Tijdsspanne: Baseline and immediately post-intervention
|
Barkley Deficits in Executive Functioning Scale - Short Form Scale; 20 items assessing the frequency at which participants have exhibited certain behaviors in specific executive functioning areas over the past 6 months.
The areas include: self-management to time, self-organization/problem-solving, self-restraint, self-motivation, and self-regulation of emotion.
Items are measured using a 4-point Likert scale, ranging from never or rarely (1) to very often (4).
|
Baseline and immediately post-intervention
|
|
Center for Epidemiologic Studies Depression Scale
Tijdsspanne: Baseline and immediately post-intervention
|
20 items; measurement of depressive symptoms.
Participants indicate responses on a 4-point item scale from rarely/none of the time to most/all of the time in 8 health dimensions: role limitations due to physical problems, social functioning, physical functioning, bodily pain, general mental health, role limitations due to emotional problems, vitality, and general health perceptions.
|
Baseline and immediately post-intervention
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Heather E Cuevas, PhD, The University of Texas at Austin
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
2 september 2016
Primaire voltooiing (Werkelijk)
10 juni 2017
Studie voltooiing (Verwacht)
1 oktober 2017
Studieregistratiedata
Eerst ingediend
12 juli 2017
Eerst ingediend dat voldeed aan de QC-criteria
14 juli 2017
Eerst geplaatst (Werkelijk)
18 juli 2017
Updates van studierecords
Laatste update geplaatst (Werkelijk)
18 juli 2017
Laatste update ingediend die voldeed aan QC-criteria
14 juli 2017
Laatst geverifieerd
1 juli 2017
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2016-08-0001
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Nee
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Diabetes mellitus, type 2
-
Instituto Nacional de Ciencias Medicas y Nutricion...Actief, niet wervend
-
Endogenex, Inc.Nog niet aan het wervenDiabetes mellitus, type 2 | Suikerziekte | Diabetes mellitus type 2 | Type 2 diabetes | Type 2 diabetes
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... en andere medewerkersWervingDiabetes mellitus type 2 (T2DM) | Diabetes noodVerenigde Staten
-
Dokuz Eylul UniversityActief, niet wervendDiabetes mellitus type 2 (T2DM) | Activering van de patiënt | Diabetes Zelfmanagement | Diabetes Mellitus (DM)Kalkoen
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationWervingDiabetes mellitus type 2 met complicatiesIndië
-
University of North Carolina, Chapel HillAmerican Heart AssociationWervingType 2 diabetes | Voeding | Diabetestype 2 | T2DM (diabetes mellitus type 2) | Diabetes mellitis | T2DM | DiabeteseducatieVerenigde Staten
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Voltooid
-
SanofiVoltooidDiabetes mellitus type 1 - Diabetes mellitus type 2Hongarije, Russische Federatie, Duitsland, Polen, Japan, Verenigde Staten, Finland
-
Endogenex, Inc.Nog niet aan het wervenDiabetes mellitus, type 2 | Suikerziekte | Type 2 diabetes | Diabetes mellitus type 2 (T2DM) | Type 2 diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Aanmelden op uitnodigingDiabetes mellitus type 2 | Veroudering | Hyperglykemie als gevolg van diabetes mellitus type 2Portugal